In this issue:
Neoadjuvant atezolizumab + chemotherapy in early-stage triple-negative breast cancer
HRT and breast cancer risk
Single-dose targeted IORT during lumpectomy for early breast cancer
Perioperative endocrine therapy for hormone-sensitive breast cancer
Adding atezolizumab to trastuzumab emtansine in HER2+ advanced breast cancer
DNA analysis to direct therapy in advanced breast cancer
Chemotherapy and survival in elderly oestrogen receptor+, node+ breast cancer
Prognostic parameters in hormone receptor+ lobular breast cancer
Evaluation of AI algorithms for assessment of screening mammograms
Veliparib + carboplatin/paclitaxel in BRCA-mutated advanced breast cancer
Please login below to download this issue (PDF)